Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Management of hand, foot and mouth disease
Hand, foot and mouth disease (HFMD) is a generally mild, but contagious, viral infection caused predominantly by coxsackieviruses.
Pharmacists in demand as COVID-19 cases continue to rise
Victoria continues to report large case numbers and NSW records its biggest spike since April.
Short-acting beta₂ agonists (salbutamol and terbutaline)
The PSA guidance document Guidance for provision of a Pharmacist Only medicine–Short-acting beta₂ agonists (salbutamol and terbutaline)2 assists in responding appropriately to a request...
Pharmacists can help improve medicine literacy
Helping consumers understand the language of medicines is the key message to emerge from this year’s Be Medicinewise Week.
To improve this understanding, PSA encourages...
Getting the most out of PSA24
Two ECPs discuss the new additions to this year’s conference program and the improvements they expect to see in their practice.
Recognising pharmacists is more important than ever
Thank Your Pharmacist Day (21 March 2024) allows all pharmacists to celebrate the profession with patients and colleagues alike.
